Skip to main content
Fanli Digital Technology Co., Ltd logo

Fanli Digital Technology Co., Ltd — Investor Relations & Filings

Ticker · 600228 ISIN · CNE000000Y78 Shanghai Stock Exchange Telecommunications, computer programming, consultancy, computing infrastructure, and other information service activities
Open in API
Filings indexed 2,248 across all filing types
Latest filing 2020-10-09 Declaration of Voting R…
Country CN China
Listing Shanghai Stock Exchange 600228

About Fanli Digital Technology Co., Ltd

https://corp.fanli.com/

Fanli Digital Technology Co., Ltd. provides e-commerce integration and digital marketing services. The company operates a comprehensive platform that connects consumers with various online retail ecosystems through value-added services such as cash-back rewards, discount coupons, and promotional insights. Its core business model focuses on performance-based marketing, utilizing data-driven strategies to facilitate sales conversions for brand partners. Key offerings include brand promotion, user loyalty management, and targeted advertising solutions. By integrating diverse shopping channels into a single interface, the company optimizes the consumer purchasing journey and provides brands with scalable traffic acquisition tools. The platform serves as a strategic intermediary, leveraging user behavioral data to enhance marketing efficiency and provide measurable returns for merchants while delivering cost savings to a broad user base.

Recent filings

Filing Released Lang Actions
2020年第三次临时股东大会决议公告
Declaration of Voting Results & Voting Rights Announcements Classification · 100% confidence The document is a detailed announcement of the resolutions passed at the 2020 third extraordinary general meeting of shareholders of Jiangxi Changjiu Bio-chemical Co., Ltd. It includes voting results for multiple proposals related to a major asset swap, issuance of shares, cash purchase of assets, and related party transactions. The document contains detailed voting statistics, meeting attendance, and legal witness statements. It is not a financial report, audit report, or earnings release. It is not a proxy solicitation or investor presentation. The content is focused on the official voting results of the shareholder meeting. Therefore, the document fits the category of Declaration of Voting Results & Voting Rights Announcements (DVA). The document length is over 14,000 characters, indicating it is the full announcement, not just a brief notice or report publication announcement.
2020-10-09 Chinese
关于本次重组相关内幕知情人买卖股票情况的自查报告
Regulatory Filings Classification · 95% confidence The document is a detailed self-inspection report regarding insider trading activities related to a major asset restructuring transaction by Jiangxi Changjiu Bio-chemical Co., Ltd. It includes descriptions of the insider registration system, the scope of insider checks, specific stock transactions by insiders, and legal opinions on the matter. The document references regulatory rules on major asset restructuring and insider trading, and it provides a comprehensive investigation and conclusion that no insider trading occurred. It is not a financial report, earnings release, or management discussion, nor is it a brief announcement or a proxy solicitation. The content is focused on compliance and legal self-inspection related to a major asset restructuring transaction, which aligns with the category of Regulatory Filings (RNS) as it is a regulatory compliance disclosure that does not fit into other specific categories like M&A filings or audit reports. The document length is 4153 characters, which is substantive and contains detailed information, not just a brief announcement or certification. Therefore, the best classification is Regulatory Filings (RNS).
2020-09-23 Chinese
2020年第三次临时股东大会资料
Capital/Financing Update Classification · 95% confidence The document is titled as materials for the "2020 Third Extraordinary General Meeting of Shareholders" of Jiangxi Changjiu Bio-chemical Co., Ltd. It contains detailed agenda items, including proposals related to a major asset swap, issuance of shares, cash purchase of assets, and related party transactions. The content includes detailed descriptions of the transaction structure, issuance of shares, pricing, lock-up arrangements, and performance commitments. The document is clearly a meeting material for a shareholders' meeting, specifically an Extraordinary General Meeting (EGM), focusing on capital and financing activities related to a major asset restructuring and share issuance. It is not a full financial report, audit report, or earnings release, but rather detailed meeting materials for shareholder approval of capital/financing transactions. Therefore, the appropriate classification is Capital/Financing Update (CAP). The document length (15,000 characters) and detailed content confirm it is not a mere announcement or notice but substantive meeting materials.
2020-09-23 Chinese
杭州同美股权投资基金合伙企业（有限合伙《﹤关于江西昌九生物化工股份有限公司股票交易异常波动的询证函﹥的回函》
Regulatory Filings Classification · 95% confidence The document is a response letter to an inquiry about abnormal stock trading fluctuations of Jiangxi Changjiu Bio-chemical Co., Ltd. It states that no undisclosed major information or transactions exist beyond what has already been disclosed. The document is short (435 characters) and is a formal reply to a regulatory inquiry rather than a financial report or announcement of financial results. It does not contain financial statements, management discussion, or detailed financial data. It is a regulatory communication related to stock trading and disclosure compliance, fitting best under Regulatory Filings (RNS).
2020-09-22 Chinese
北京市文化中心建设发展基金管理有限公司《﹤关于江西昌九生物化工股份有限公司股票交易异常波动的询证函﹥的回函》
Regulatory Filings Classification · 95% confidence The document is a response letter regarding an inquiry about abnormal stock trading fluctuations of Jiangxi Changjiu Bio-chemical Co., Ltd. It states that no undisclosed major information exists and denies any trading activity during the abnormal fluctuation period. The document is short (435 characters) and is a formal reply to a regulatory inquiry rather than a financial report or announcement of financial results. It does not contain financial data, management changes, voting results, or other report types. It fits best as a Regulatory Filing (RNS) because it is a compliance-related communication that does not fit other specific categories.
2020-09-22 Chinese
上海文心智合企业发展有限公司《﹤关于江西昌九生物化工股份有限公司股票交易异常波动的询证函﹥的回函》
Regulatory Filings Classification · 95% confidence The document is a response letter to an inquiry about abnormal stock trading fluctuations of Jiangxi Changjiu Bio-chemical Co., Ltd. It states that no undisclosed major information exists and denies any trading of the company's stock during the abnormal period. The document is short (427 characters) and is a formal reply to a regulatory inquiry rather than a financial report or announcement of financial results. It does not contain financial data, management changes, voting results, or other report content. Therefore, it fits best under Regulatory Filings (RNS), which covers miscellaneous regulatory announcements and compliance documents that do not fit other categories.
2020-09-22 Chinese

Browse filings by year

28 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.